HEMATOLOGIC MALIGNANCY

This study is testing whether a medication called tocilizumab can help improve bone marrow transplants for people with blood cancers. Researchers want to see if using tocilizumab instead of another standard drug can help the transplant work better while reducing serious complicat…

This study follows patients who previously received AvenCell's CAR-T cell therapy in earlier clinical trials. Researchers want to understand the long-term safety and effectiveness of these cancer treatments over time. The study will track 178 patients with various blood cancers a…

This study aims to see if a blood test that measures the immune system's strength against a common virus (CMV) can help doctors decide how long to give a preventive antiviral drug. It involves 250 adults who have received a stem cell transplant for blood cancer. The goal is to be…

This early-stage study is testing whether immune cells from healthy donors, given along with two other drugs, are safe for people with advanced colorectal, stomach, or hard-to-treat blood cancers. The goal is to see if this combination helps the donor immune cells last longer in …

This study is testing whether a 4-week online writing workshop can improve mental wellness for young adults with blood cancer. Participants are randomly assigned to either start the workshop right away or wait 4 weeks, and they complete surveys over 12 weeks. Researchers are comp…

This study is testing whether a phone-based mental wellness program can help caregivers of bone marrow transplant patients feel better. The program teaches positive thinking skills to reduce stress, anxiety, and depression. Researchers will compare the program's effects to regula…

This study is testing whether a mobile app can improve the well-being of people caring for loved ones undergoing bone marrow transplants for cancer. About 120 caregivers will either use the CARE app along with standard support or receive standard support alone. Researchers will m…

This study collects tumor tissue and blood samples from people with cancer to help researchers find new targets for future treatments. Participants are adults who are already having surgery or biopsy for their cancer care. No experimental treatments are given—researchers only col…

This study aims to learn how well COVID-19 vaccines protect children and young adults under 24 who have cancer or have received a transplant or cellular therapy. Researchers will measure the strength and duration of the immune response in these vulnerable patients by taking small…